Related Experiment Video

Updated: Aug 14, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Cryoglobulinemic vasculitis

Clodoveo Ferri1, Maria Teresa Mascia

  • 1Chair and Rheumatology Unit, Department of Internal Medicine, University of Modena e Reggio Emilia, Medical School, Modena, Italy. clferri@unimore.it

Current Opinion in Rheumatology
|December 14, 2005
PubMed

Insights

Hepatitis C virus (HCV) drives cryoglobulinemic vasculitis by stimulating the immune system, leading to autoantibodies and potential B-cell lymphomas. Treatment strategies for this condition are tailored to individual patient needs.

Area of Science:

  • Immunology
  • Virology
  • Rheumatology

Background:

  • Cryoglobulinemic vasculitis is a systemic vasculitis affecting small-medium vessels.
  • Hepatitis C virus (HCV) is implicated in over 80% of cases.
  • Understanding the interplay between HCV and the immune system is crucial.

Purpose of the Study:

  • To review recent advances in the etiopathogenesis, diagnosis, and treatment of cryoglobulinemic vasculitis.
  • To explore the role of HCV in the development of this condition.
  • To highlight the complex relationship between autoimmune and lymphoproliferative disorders.

Main Methods:

  • Literature review of recent studies on cryoglobulinemic vasculitis.
  • Analysis of the pathogenetic mechanisms involving HCV.
  • Examination of clinical presentations and diagnostic challenges.
  • Evaluation of current and emerging therapeutic strategies.

Main Results:

  • HCV chronic infection can lead to immune system stimulation, B-cell activation, and autoantibody production.
  • The interaction of HCV envelope protein E2 with CD81 receptor may promote B-cell survival and oncogene activation.
  • Cryoglobulinemic vasculitis can be associated with malignancies, particularly B-cell lymphomas.
  • Overlap with other conditions like Sjögren's syndrome and autoimmune hepatitis requires careful diagnosis.
  • Survival rates for cryoglobulinemic vasculitis patients are lower than the general population.

Conclusions:

  • Cryoglobulinemic vasculitis serves as a model for studying virus-related autoimmune and lymphoproliferative disorders.
  • HCV is a primary driver, making etiological treatment essential.
  • Personalized therapeutic approaches combining antiviral, pathogenetic, and symptomatic treatments are necessary.
Abstract

Related Concept Videos

Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...